Screener
BioCryst Pharmaceuticals BCRX Product — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product sales, net | $157,513 | $162,430 | $308,914 | $306,217 |
| License and other revenues | 60,737 | 923 | 65,749 | 2,670 |
| Total revenues | 218,250 | 163,353 | 374,663 | 308,887 |
| Expenses: | ||||
| Cost of product sales | 3,840 | 2,798 | 9,217 | 7,366 |
| Acquired in-process research and development | — | — | 697,761 | — |
| Research and development | 51,969 | 43,386 | 112,288 | 80,656 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's product — total revenues?
- BioCryst Pharmaceuticals (BCRX) reported product — total revenues of $157.51M in Q2 2026.
- How has BioCryst Pharmaceuticals's product — total revenues changed year-over-year?
- BioCryst Pharmaceuticals's product — total revenues decreased by 3.0% year-over-year, from $162.43M to $157.51M.
- What is the long-term trend for BioCryst Pharmaceuticals's product — total revenues?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's product — total revenues has grown at a 46.2% compound annual growth rate (CAGR), from $136.35M to $623.15M.
- What does product — total revenues mean?
- This metric represents the total net revenue generated from the sale of pharmaceutical products within a specific business segment. It reflects the company's ability to commercialize its drug portfolio and serves as a primary indicator of market adoption for its therapeutic offerings. This figure is calculated after accounting for returns, discounts, and allowances associated with product distribution.
Ask your AI about BioCryst Pharmaceuticals's product — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude